SEC 13F Intelligence

Palo Alto Investors LP / UTH

Palo Alto Investors LP’s United Therapeutics Corp Del Position

Does Palo Alto Investors LP own United Therapeutics Corp Del (UTH)? Yes — 62.8K shares worth $37M (+5.70% of its 13F portfolio) as of Q1 2026, up from 58.2K shares the prior filed quarter.

Position Value
$37M
Q1 2026
Shares
62.8K
% of Portfolio
+5.70%
Quarters Held
30
currently held

Position History UTH

Reported value by quarter
Q4 ’18: $178MQ4 ’18Q1 ’19: $192MQ2 ’19: $121MQ3 ’19: $114MQ4 ’19: $114MQ4 ’19Q1 ’20: $83MQ2 ’20: $93MQ3 ’20: $79MQ4 ’20: $119MQ4 ’20Q1 ’21: $115MQ2 ’21: $123MQ3 ’21: $127MQ4 ’21: $148MQ4 ’21Q1 ’22: $117MQ2 ’22: $150MQ3 ’22: $133MQ4 ’22: $174MQ4 ’22Q1 ’23: $141MQ2 ’23: $139MQ3 ’23: $130MQ4 ’23: $87MQ4 ’23Q1 ’24: $62MQ2 ’24: $85MQ3 ’24: $66MQ4 ’24: $55MQ4 ’24Q1 ’25: $32MQ2 ’25: $27MQ3 ’25: $24MQ4 ’25: $28MQ4 ’25Q1 ’26: $37Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202662.8K$37M+5.70%
Q4 202558.2K$28M+3.95%
Q3 202558.2K$24M+4.51%
Q2 202595.5K$27M+5.84%
Q1 2025105.2K$32M+6.18%
Q4 2024155.7K$55M+8.51%
Q3 2024183.2K$66M+8.53%
Q2 2024266.9K$85M+9.85%
Q1 2024267.8K$62M+6.94%
Q4 2023395.8K$87M+7.84%
Q3 2023575.9K$130M+12.31%
Q2 2023627.5K$139M+11.19%
Q1 2023627.5K$141M+11.64%
Q4 2022625.4K$174M+14.83%
Q3 2022633.5K$133M+10.49%
Q2 2022634.8K$150M+13.04%
Q1 2022653.1K$117M+9.06%
Q4 2021687.2K$148M+9.49%
Q3 2021687.2K$127M+7.66%
Q2 2021687.2K$123M+6.79%
Q1 2021687.2K$115M+6.55%
Q4 2020785.4K$119M+6.25%
Q3 2020785.4K$79M+4.35%
Q2 2020766.4K$93M+5.57%
Q1 2020876.6K$83M+6.96%
Q4 20191.29M$114M+6.25%
Q3 20191.42M$114M+7.57%
Q2 20191.55M$121M+5.89%
Q1 20191.63M$192M+7.99%
Q4 20181.63M$178M+9.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Palo Alto Investors LP’s full portfolio or all institutional holders of UTH.